Drug
naropin
naropin is a pharmaceutical drug with 5 clinical trials. Historical success rate of 100.0%.
Total Trials
5
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 3 completed trials
Completion Rate
100%(3/3)
Active Trials
0(0%)
Results Posted
33%(1 trials)
Phase Distribution
Ph phase_2
1
20%
Ph not_applicable
1
20%
Ph phase_1
2
40%
Ph phase_3
1
20%
Phase Distribution
2
Early Stage
1
Mid Stage
1
Late Stage
Phase Distribution5 total trials
Phase 1Safety & dosage
2(40.0%)
Phase 2Efficacy & side effects
1(20.0%)
Phase 3Large-scale testing
1(20.0%)
N/ANon-phased studies
1(20.0%)
Highest Phase Reached
Phase 3Trial Status & Enrollment
Completion Rate
75.0%
3 of 4 finished
Non-Completion Rate
25.0%
1 ended early
Currently Active
0
trials recruiting
Total Trials
5
all time
Status Distribution
Completed(3)
Terminated(1)
Other(1)
Detailed Status
Completed3
unknown1
Withdrawn1
Development Timeline
Analytics
Development Status
Total Trials
5
Active
0
Success Rate
100.0%
Most Advanced
Phase 3
Trials by Phase
Phase 12 (40.0%)
Phase 21 (20.0%)
Phase 31 (20.0%)
N/A1 (20.0%)
Trials by Status
completed360%
unknown120%
withdrawn120%
Recent Activity
0 active trials
Showing 5 of 5
withdrawnphase_3
Peri-Incisional Drug Injection in Lumbar Spine Surgery
NCT03513445
completedphase_1
Phase I/II Dose-escalation Study to Evaluate Safety, PK and Efficacy of TLC590 for Postsurgical Pain Management
NCT03591146
unknownphase_1
A Trial of HR18034 in Inguinal Hernia Repair
NCT04551924
completedphase_2
A Study to Evaluate Safety, PK, Efficacy of TLC590 for Postsurgical Pain Management Following Bunionectomy
NCT03838133
completednot_applicable
Analgesia After Total Knee Replacement Surgery
NCT01489631
Clinical Trials (5)
Showing 5 of 5 trials
NCT03513445Phase 3
Peri-Incisional Drug Injection in Lumbar Spine Surgery
NCT03591146Phase 1
Phase I/II Dose-escalation Study to Evaluate Safety, PK and Efficacy of TLC590 for Postsurgical Pain Management
NCT04551924Phase 1
A Trial of HR18034 in Inguinal Hernia Repair
NCT03838133Phase 2
A Study to Evaluate Safety, PK, Efficacy of TLC590 for Postsurgical Pain Management Following Bunionectomy
NCT01489631Not Applicable
Analgesia After Total Knee Replacement Surgery
All 5 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 5